The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51–60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant Registry
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Xin Zhao, Ming Zhou, Bao‐Dong Ye, Er‐Lie Jiang, Dai‐Hong Liu, Peihua Lu, Fang Zhou, Gui‐Fang Ou‐Yang, Ya‐Jing Xu, Xin Li, Wei‐Wei Qin, Hai Yi, Guan‐Chen Bai, Zi‐Min Sun, Xue‐Jun Zhang, Xue‐Hong Ran, Jian‐Ping Zhang, Guo‐Hong Su, Jin‐Xiong Huang, Tai‐Wu Xiao, Xian‐Min Song, Hui‐Xia Liu, Jin‐Song Yan, Ke‐Hong Bi, Xi Zhang, Xiao‐Jun Huang, Shun‐Qing Wang, Lan‐Ping Xu |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Severely Underweight Patient with Aplastic Anemia
por: Lilija Banceviča, et al.
Publicado: (2024)
por: Lilija Banceviča, et al.
Publicado: (2024)
Peripheral versus Marrow Lipidomics in Patients with Severe Aplastic Anemia: Potential Indicators for Early Immunosuppressive Treatment Response
por: Zexing Sun, et al.
Publicado: (2026)
por: Zexing Sun, et al.
Publicado: (2026)
Case Report: Hematopoietic Stem Cell Transplantation to Treat Severe Acquired Aplastic Anemia in a Pediatric Kidney Transplant Recipient
por: Gintarė Mierkienė, et al.
Publicado: (2025)
por: Gintarė Mierkienė, et al.
Publicado: (2025)
Hetrombopag Added to Cyclosporine as the First‐Line Treatment for Patients With Non‐Severe Aplastic Anemia: A Phase 2 Multicenter Trial
por: Lele Zhang, et al.
Publicado: (2026)
por: Lele Zhang, et al.
Publicado: (2026)
Controlling Renal Chronic Graft‐Versus‐Host Disease With a Belumosudil‐Containing Regimen After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Yimin Wang, et al.
Publicado: (2025)
por: Yimin Wang, et al.
Publicado: (2025)
X‐Linked Sideroblastic Anemia Caused by ALAS2 Intron 1 Mutation Successfully Treated by Allogenic Hematopoietic Stem Cell Transplant
por: Shurui Du, et al.
Publicado: (2026)
por: Shurui Du, et al.
Publicado: (2026)
MRD and NK‐Cell Chimerism Predict Transplant Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Xing Chen, et al.
Publicado: (2025)
por: Xing Chen, et al.
Publicado: (2025)
Loss‐Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia
por: Yoshitaka Zaimoku, et al.
Publicado: (2025)
por: Yoshitaka Zaimoku, et al.
Publicado: (2025)
Adverse Impact of Pre‐Transplant Liver Dysfunction in Allogeneic Hematopoietic Cell Transplantation
por: Yukiko Misaki, et al.
Publicado: (2025)
por: Yukiko Misaki, et al.
Publicado: (2025)
Dynamic Immune Reconstitution and Clinical Outcomes of Three Different Protocols for Haploidentical Hematopoietic Stem Cell Transplantation
por: Xiao‐Di Ma, et al.
Publicado: (2026)
por: Xiao‐Di Ma, et al.
Publicado: (2026)
The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation
por: Wenjing Hao, et al.
Publicado: (2026)
por: Wenjing Hao, et al.
Publicado: (2026)
Five‐Aminolevulinic Acid as a Potential Biomarker for Renal Insufficiency After Heart Transplantation
por: Xiao Huang, et al.
Publicado: (2025)
por: Xiao Huang, et al.
Publicado: (2025)
Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant
por: George L. Chen, et al.
Publicado: (2026)
por: George L. Chen, et al.
Publicado: (2026)
Post‐Transplant Bendamustine as a Platform for Immune Modulation After Allogeneic Hematopoietic Cell Transplantation
por: Megan J. Cracchiolo, et al.
Publicado: (2026)
por: Megan J. Cracchiolo, et al.
Publicado: (2026)
Association of CYP2C19 Single Nucleotide Polymorphism With Hemorrhagic Cystitis After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
por: Weiliang Zhang, et al.
Publicado: (2026)
por: Weiliang Zhang, et al.
Publicado: (2026)
Formula Probiotic Fermentation After Enzymatic Pretreatment Enhances Immunomodulatory Effects of Edible Seaweed Sargassum fusiforme via Gut Microbial Regulation
por: Jun‐Fang Zhang, et al.
Publicado: (2026)
por: Jun‐Fang Zhang, et al.
Publicado: (2026)
Transplantation Related Mortality Did Not Show Significant Differences in Patients Aged Above 55 Years With Hematological Malignancies Receiving Allogeneic Hematopoietic Stem Cell Transplantation in a Real‐World Study
por: Jing Liu, et al.
Publicado: (2025)
por: Jing Liu, et al.
Publicado: (2025)
Adenovirus‐Associated Opsoclonus After Allogeneic Hematopoietic Stem Cell Transplantation
por: Toru Miyajima, et al.
Publicado: (2026)
por: Toru Miyajima, et al.
Publicado: (2026)
Allogeneic HSCT in Aplastic Anemia: Current Evidence, Controversies, and Practical Decision‐Making
por: Arjun Datt Law, et al.
Publicado: (2026)
por: Arjun Datt Law, et al.
Publicado: (2026)
Enhanced structural stability and magnetism of SmCo 3 permanent magnet doped with 3d transition metals: an ab initio study
por: Cheng Fang, et al.
Publicado: (2024)
por: Cheng Fang, et al.
Publicado: (2024)
Correction to “Successful Haploidentical Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria With Severe Pancytopenia Developed After Long‐Term Aplastic Anemia Treatment”
Publicado: (2025)
Publicado: (2025)
Metabolomics Analysis Using Chromatography–Mass Spectrometry to Investigate the Mechanism of Cyclosporine in the Treatment of Aplastic Anemia
por: Ming‐xin Guo, et al.
Publicado: (2025)
por: Ming‐xin Guo, et al.
Publicado: (2025)
CSF3R Mutations in Hematological Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Jiaxin Cao, et al.
Publicado: (2025)
por: Jiaxin Cao, et al.
Publicado: (2025)
Bell nonlocality and entanglement in $χ_{cJ}$ decays into baryon pair
por: Hong, PengCheng, et al.
Publicado: (2025)
por: Hong, PengCheng, et al.
Publicado: (2025)
Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First Transplantation
por: Kazuki Yoshimura, et al.
Publicado: (2025)
por: Kazuki Yoshimura, et al.
Publicado: (2025)
Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation
por: Mary Nauffal, et al.
Publicado: (2024)
por: Mary Nauffal, et al.
Publicado: (2024)
Increasing Access to Pediatric Allogeneic Hematopoietic Stem Cell Transplantation in South Africa
por: Candice Laverne Hendricks, et al.
Publicado: (2026)
por: Candice Laverne Hendricks, et al.
Publicado: (2026)
Comparison of Hetrombopag and Eltrombopag Added to First‐Line Immunosuppressive Therapy in Severe Aplastic Anemia
por: Baohang Zhang, et al.
Publicado: (2025)
por: Baohang Zhang, et al.
Publicado: (2025)
Retracted: Bone Marrow Plasma Cytokine Signature Profiles in Severe Aplastic Anemia
por: BioMed Research International
Publicado: (2024)
por: BioMed Research International
Publicado: (2024)
Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia
por: Wei Zhang, et al.
Publicado: (2024)
por: Wei Zhang, et al.
Publicado: (2024)
Clinical and Economic Burden of Cytomegalovirus (CMV) Infection/Disease Among Hospitalized Adult Allogeneic Hematopoietic Stem Cell Transplant (Allo‐HSCT) Recipients in China
por: Chenhua Yan, et al.
Publicado: (2025)
por: Chenhua Yan, et al.
Publicado: (2025)
Pediatric Mixed Phenotype Acute Leukemia With ETV6 :: ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation
por: Yaoyao Rui, et al.
Publicado: (2025)
por: Yaoyao Rui, et al.
Publicado: (2025)
Consensus Integration of Multiomics Data With Machine Learning Algorithms Reveals Heterogeneous Molecular Subtypes and Enables Personalized Treatment Strategies for Hepatocellular Carcinoma
por: Zhipeng Jin, et al.
Publicado: (2025)
por: Zhipeng Jin, et al.
Publicado: (2025)
Severe HCoV‐OC43 Pneumonia in a 25‐Year‐Old Woman Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Mingzhou Zhang, et al.
Publicado: (2026)
por: Mingzhou Zhang, et al.
Publicado: (2026)
The Osteoblastic Microenvironment Determines the Fate of Breast Cancer Cells Disseminated in the Bone Marrow
por: Hong‐Li Wang, et al.
Publicado: (2026)
por: Hong‐Li Wang, et al.
Publicado: (2026)
Return‐to‐School Experiences of Adolescents After Allogeneic Hematopoietic Cell Transplant: A Qualitative Interview Study of Transplant Recipients
por: Olivia A. Do, et al.
Publicado: (2024)
por: Olivia A. Do, et al.
Publicado: (2024)
Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Nihar Desai, et al.
Publicado: (2024)
por: Nihar Desai, et al.
Publicado: (2024)
VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?
por: Eva de Berranger, et al.
Publicado: (2024)
por: Eva de Berranger, et al.
Publicado: (2024)
Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
por: Hiroki Hosoi, et al.
Publicado: (2025)
por: Hiroki Hosoi, et al.
Publicado: (2025)
Puerarin Attenuates Podocyte Damage in Mice With Diabetic Kidney Disease by Modulating the AMPK/Nrf2 Pathway
por: Song Xue, et al.
Publicado: (2025)
por: Song Xue, et al.
Publicado: (2025)
Ejemplares similares
-
A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Severely Underweight Patient with Aplastic Anemia
por: Lilija Banceviča, et al.
Publicado: (2024) -
Peripheral versus Marrow Lipidomics in Patients with Severe Aplastic Anemia: Potential Indicators for Early Immunosuppressive Treatment Response
por: Zexing Sun, et al.
Publicado: (2026) -
Case Report: Hematopoietic Stem Cell Transplantation to Treat Severe Acquired Aplastic Anemia in a Pediatric Kidney Transplant Recipient
por: Gintarė Mierkienė, et al.
Publicado: (2025) -
Hetrombopag Added to Cyclosporine as the First‐Line Treatment for Patients With Non‐Severe Aplastic Anemia: A Phase 2 Multicenter Trial
por: Lele Zhang, et al.
Publicado: (2026) -
Controlling Renal Chronic Graft‐Versus‐Host Disease With a Belumosudil‐Containing Regimen After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Yimin Wang, et al.
Publicado: (2025)